Skip to main content

First Stem-cell-based Drug Approved in Canada

First Stem-cell-based Drug Approved in Canada

On Thursday the New York Times reported that Canadian regulators had approved Prochymal, the first stem cell-based drug, a product of Osiris Therapeutics of Maryland. Prochymal is a treatment for children suffering from graft-versus-host disease following bone marrow transplantation.

“It’s really a good day for the concept and the hope behind stem cell therapies becoming a reality,” C. Randal Mills, the chief executive of Osiris, said in an interview.

Read full coverage by the Times' Andrew Pollack.

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.